Canada’s Tekmira To Produce Experimental Ebola Treatment For U.S. DoD
Reuters: Tekmira to produce Ebola treatment for U.S. Dept of Defense
“The U.S. Department of Defense has exercised an option with Canada’s Tekmira Pharmaceuticals Corp. for the company to make 500 courses of its experimental treatment for Ebola, Tekmira said on Thursday. The treatment targets the Ebola-Guinea virus variant, which is responsible for the worst outbreak on record that has hit hardest in Liberia, Sierra Leone, and Guinea. It works by preventing the virus from replicating…” (11/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.